Bioavailability of magnetic nanoparticles to the brain
Source abstract
Abstract
This study investigates the bioavailability of carboxymethyl dextran-coated magnetic nanoparticles (CMD-MNP) to the brain. The cytotoxicity of CMD-MNP was assessed by co-culture with C6, a rat glioma cell line. To investigate the effects of an external magnetic field on the biodistribution of nanoparticles in a rat model, a magnet of 0.3 Tesla was applied externally over the cranium and the particles injected via the external jugular vein. Nanoparticles were also injected into rats implanted with C6 tumor cells. Staining of histological samples with Prussian blue to detect iron particles revealed that the external magnetic field enhanced the aggregation of nanoparticles in the rat brain; this enhancement was even more pronounced in the tumor region.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Microtubule and mitosis dynamics · Radiation Therapy and Dosimetry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (9)
Show source-provided references
1. Mclean · Colloids Surf. B Biointerfaces · 2000 · 18 · 22110.1016/S0927-7765(99)00149-6 ↗
2. Wagner · Appl. Organomet. Chem. · 2004 · 18 · 51410.1002/aoc.752 ↗
3. Grobben · Cell Tissue Res. · 2002 · 310 · 25710.1007/s00441-002-0651-7 ↗
4. Grogan · Adv. Anat. Pathol. · 2000 · 7 · 11010.1097/00125480-200007020-00006 ↗
5. Monsky · Cancer Res. · 1999 · 59 · 4129
6. Saxena · Int. J. Pharm. · 2006 · 308 · 20010.1016/j.ijpharm.2005.11.003 ↗
7. Wu · J. Magn. Magn. Mater. · 2007 · 311 · 37210.1016/j.jmmm.2006.10.1202 ↗
8. Begley · Pharmacol. Ther. · 2004 · 104 · 2910.1016/j.pharmthera.2004.08.001 ↗
9. Neuwelt · Neurosurgery · 2004 · 54 · 13110.1227/01.NEU.0000097715.11966.8E ↗